A recent clinical trial demonstrated that high levels of Ang2 were an independent predictor of mortality in patients with acute myocardial infarction; it also suggested that an increase in plasma Ang2 levels might partly reflect persistent endothelial damage in ischemic heart conditions [48]. This evidence concerns the gene ANGPT2 and acute myocardial infarction.